Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3-Day vs 5-Day Artemether-lumefantrine for Uncomplicated Falciparum Malaria
NCT02020330Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Nov 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of artemether + lumefantrine in Malaria, sponsored by University of Oxford. Started Nov 2013; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT02020330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02020330.